Jose Cancelas
Physician · Cincinnati Children's Hospital Medical Center
Credentials: · · ·
History
Hospital Ramon y Cajal
Pathology-Anatomic and Clinical
Research
Hematopoietic cell regulation by Rac1 and Rac2 guanosine triphosphatases
Science · 2003 · 398 citations
Microenvironment determines lineage fate in a human model of MLL-AF9 leukemia
Cancer Cell · 2008 · 265 citations
Rac GTPases differentially integrate signals regulating hematopoietic stem cell localization
Nature Medicine · 2005 · First of 6 authors · 223 citations
28 papers
- AS
13 papers
10 papers
10 papers
8 papers · 3 as a fellow
8 papers
8 papers
7 papers
Grants
- 2026–2031
Concomitant Inhibition of VAV3 and ERa to Treat High-Risk B-ALL
National Cancer Institute · R01
PI · $683.7K · Cincinnati Childrens Hosp Med Ctr
- 2020–2030
Mitochondria Mediated Intercellular Metabolic Coupling in Bone Marrow Regeneration
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $1.9M · Dana-Farber Cancer Inst
- 2021–2028
Cincinnati Cooperative Center of Excellence in Hematology
National Institute of Diabetes and Digestive and Kidney Diseases · U54
Project lead · $487.6K · Cincinnati Childrens Hosp Med Ctr
- 2022–2027
Novel Strategies to Improve Blood Transfusion Practice
National Heart, Lung, and Blood Institute · P01
Project lead · $1.3M · Brigham and Women's Hospital
Clinical trials
- 2026–2027
Principal investigator · Recruiting · Phase 1
Jose Cancelas
- 2021–2022
An In Vivo 24-Hour Recovery Study of Whole Blood by the Reveos System
Principal investigator · Completed
Terumo BCT
- 2020–2021
Principal investigator · Withdrawn · Phase 2
Hemanext
- 2017
Principal investigator · Completed
Terumo BCT